Contaminated alcohol prep pad may have caused sudden death of two year old

A lawsuit filed in Federal court claims that a contaminated alcohol prep pad manufactured by Triad Group, Inc. caused the sudden death of a two year old boy.  The lawsuit claims Bacillus cereus bacteria from a contaminated alcohol prep pad caused a deadly meningitis infection.

"This little boy had undergone a relatively simple procedure for a benign cyst," says attorney Jim Perdue, Jr. in the lawsuit. "He was recovering well until he contracted a Bacillus cereus infection, which is not normally a hospital-acquired infection. Hospital staff had no idea how the bacteria got into the boy's spinal fluid."

On January 3, 2011, a month after the boy's death, Triad Group announced a nationwide recall of all lots of its alcohol pads and swabs due to concerns of Bacillus cereus contamination.

"The missing piece of the puzzle came when the FDA announced the recall for the Triad alcohol pads and swabs for the exact bacteria contamination that killed my son," says his mother, Sandra Kothari.  "These alcohol wipes are used every day in hospitals, clinics and homes.  People think they're safe."

The Food and Drug Administration's website says "use of contaminated Triad Alcohol Group Prep Pads, Alcohol Swabs or Alcohol Swabsticks could lead to life-threatening infections, especially in at-risk populations, including immune suppressed and surgical patients."  Triad Group has sold millions of these alcohol prep products in the US, Canada and Europe.

Triad Group Alcohol Prep products are used to disinfect an area prior to an injection. They were distributed to hospitals, retail pharmacies, and were included in a number of prepackaged injection kits.  The affected products were marketed under the "Triad Group" label and many other private labels.

Source:

Perdue & Kidd, L.L.P.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder